Your browser doesn't support javascript.
loading
Potential advantages of genetically modified mesenchymal stem cells in the treatment of acute and chronic liver diseases.
Sani, Farnaz; Sani, Mahsa; Moayedfard, Zahra; Darayee, Maryam; Tayebi, Lobat; Azarpira, Negar.
Affiliation
  • Sani F; Hematology and Cell Therapy Department, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
  • Sani M; Department of Tissue Engineering and Cell Therapy, School of Advanced Technologies in Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Moayedfard Z; Department of Tissue Engineering and Cell Therapy, School of Advanced Technologies in Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Darayee M; Department of Molecular Medicine, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Tayebi L; Marquette University School of Dentistry, Milwaukee, WI, 53233, USA.
  • Azarpira N; Transplant Research Center, Shiraz University of Medical Sciences, Khalili Street, P.O. Box: 7193711351, Shiraz, Iran. negarazarpira@gmail.com.
Stem Cell Res Ther ; 14(1): 138, 2023 05 24.
Article in En | MEDLINE | ID: mdl-37226279
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Liver Failure, Acute / Mesenchymal Stem Cells Limits: Humans Language: En Journal: Stem Cell Res Ther Year: 2023 Document type: Article Affiliation country: Irán Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Liver Failure, Acute / Mesenchymal Stem Cells Limits: Humans Language: En Journal: Stem Cell Res Ther Year: 2023 Document type: Article Affiliation country: Irán Country of publication: Reino Unido